Aarti Pharmalabs has issued a formal clarification regarding the delay in submitting an event disclosure required within 24 hours. The company stated that the necessary email containing the query was received while the concerned official was on leave between February 3rd and February 5th, 2026. This resulted in an inadvertent delay, as the matter was only addressed upon the official’s return.
Explanation for Disclosure Delay
Aarti Pharmalabs Limited has addressed a previous Corporate Announcement submitted on February 6, 2026, concerning a delay in disclosure to the stock exchange. The company confirmed that the requirement mandated a disclosure within a strict 24-hour timeline.
Circumstances Leading to the Lateness
The delay occurred because the official responsible for handling the regulatory query was unexpectedly on leave from February 3rd to February 5th, 2026. The specific email communication detailing the query was received during this period. Consequently, the matter could not be attended to until the official returned, which led to the inadvertent delay in disclosure.
Resolution and Record Keeping
The company expressed its hope that this clarification adequately addresses the matter and requested the exchange to take this explanation on record. The clarification was officially signed and dated on February 13, 2026, by Mr. Jeevan Mondkar, Company Secretary and Legal Head.
Source: BSE
